Brief: Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA for the Treatment of Niemann-Pick Disease Type C (NPC)

Zevra Therapeutics

29/12/2025 13:20

Dec 29 (Reuters) - Zevra Therapeutics Inc ZVRA.O:

ZEVRA THERAPEUTICS EXECUTES DISTRIBUTION AGREEMENT TO BROADEN ACCESS TO MIPLYFFA® FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C (NPC)

ZEVRA THERAPEUTICS INC - AGREEMENT ENABLES NPC PATIENTS TO ACCESS MIPLYFFA OUTSIDE EUROPE

Source text: ID:nGNX4mz3fx

Further company coverage: ZVRA.O

 ((Reuters.Briefs@thomsonreuters.com;))